Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin.
作者信息
Greenshaw Andrew J
出版信息
J Psychiatry Neurosci. 2003 Jul;28(4):247-50.
Abstract
摘要
相似文献
1
Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin.
J Psychiatry Neurosci. 2003 Jul;28(4):247-50.
2
[Old and new thought concepts on the biochemical principles of psychopharmcotherapy].
Samml Zwangl Abh Geb Psychiatr Neurol. 1982;50:61-80.
3
[The future of biological psychiatry].
Duodecim. 1985;101(17):1732-7.
4
[Neurotransporters : new aspects of the mechanism of action of psychotropic drugs].
Nervenarzt. 1993 Jan;64(1):75-9.
5
Recent developments in neurobiology: Part II. Neurotransmitter receptors and psychopharmacology.
Psychosomatics. 1988 Summer;29(3):254-63. doi: 10.1016/S0033-3182(88)72361-0.
6
[Neurochemical strategy in the study of the mechanism of action of currently used antipsychotic drugs].
Vestn Ross Akad Med Nauk. 1992(7):21-5.
7
Prolegomenon to the clinical prerequisite: psychopharmacology and the classification of mental disorders.
Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(5):527-80. doi: 10.1016/0278-5846(87)90019-4.
8
[Psychopharmaceuticals as instruments for research].
Cesk Psychiatr. 1988 Feb;84(1):28-35.
9
Deconstructing psychiatric disorders, part 2: An emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist.
J Clin Psychiatry. 2003 Oct;64(10):1145-6.
10
Psychoactive drug use in evolutionary perspective.
Science. 1997 Oct 3;278(5335):63-6. doi: 10.1126/science.278.5335.63.
引用本文的文献
1
Behavioral training reverses global cortical network dysfunction induced by perinatal antidepressant exposure.
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2233-8. doi: 10.1073/pnas.1416582111. Epub 2015 Feb 2.
本文引用的文献
1
Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.
J Psychiatry Neurosci. 2003 May;28(3):171-81.
2
Comparison of fMRI activation at 3 and 1.5 T during perceptual, cognitive, and affective processing.
Neuroimage. 2003 Apr;18(4):813-26. doi: 10.1016/s1053-8119(03)00002-8.
3
Imaging genomics.
Br Med Bull. 2003;65:259-70. doi: 10.1093/bmb/65.1.259.
4
Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment.
Br Med Bull. 2003;65:193-207. doi: 10.1093/bmb/65.1.193.
5
Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia.
Am J Psychiatry. 2003 Apr;160(4):709-19. doi: 10.1176/appi.ajp.160.4.709.
6
Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness.
Neuroimage. 2003 Mar;18(3):760-8. doi: 10.1016/s1053-8119(03)00004-1.
7
The pharmacology of putative early-onset antidepressant strategies.
Eur Neuropsychopharmacol. 2003 Mar;13(2):57-66. doi: 10.1016/s0924-977x(02)00173-6.
8
Increased cortical GABA concentrations in depressed patients receiving ECT.
Am J Psychiatry. 2003 Mar;160(3):577-9. doi: 10.1176/appi.ajp.160.3.577.
9
Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
Am J Psychiatry. 2003 Feb;160(2):303-9. doi: 10.1176/appi.ajp.160.2.303.
10
An fMRI study investigating cognitive modulation of brain regions associated with emotional processing of visual stimuli.
Neuropsychologia. 2003;41(5):585-96. doi: 10.1016/s0028-3932(02)00199-9.
Zotero 插件